Phase 1, Phosphoinositide 3-kinase inhibitor, open-label crossover study
Showing 26 - 50 of >10,000
Lung Cancer Trial (TILT-123, Pembrolizumab)
Not yet recruiting
- Lung Cancer
- TILT-123
- Pembrolizumab
- (no location specified)
Nov 5, 2023
Gastrointestinal Tumor Trial in Hangzhou (Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T,
Completed
- Gastrointestinal Tumor
- Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T, Germany)
- tislelizumab (BeiGene, China) combined with PD-1 inhibitor
-
Hangzhou, ChinaZhejiang Hospital
Sep 1, 2023
Generalized Myasthenia Gravis Trial (Rozanolixizumab)
Not yet recruiting
- Generalized Myasthenia Gravis
- (no location specified)
Jan 4, 2023
Healthy Volunteers Trial (Brensocatib, Clarithromycin)
Not yet recruiting
- Healthy Volunteers
- (no location specified)
Jul 19, 2023
Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitor, Radiotherapy Trial (radiation, drug, biological)
Not yet recruiting
- Nasopharyngeal Carcinoma
- +3 more
- Intensity Modulated Radiation Therapy
- +3 more
- (no location specified)
Jul 11, 2023
Hepatocellular Carcinoma, Solid Tumor, Hepatocellular Carcinoma Non-resectable Trial in San Antonio (OTX-2002, Tyrosine kinase
Not yet recruiting
- Hepatocellular Carcinoma
- +6 more
- OTX-2002
- +3 more
-
San Antonio, TexasNext Oncology
Aug 9, 2022
Healthy Adult Subjects Trial in San Antonio (TTYP01, Radicava, Radicava ORS)
Recruiting
- Healthy Adult Subjects
- TTYP01
- +2 more
-
San Antonio, TexasICON Early Phase Services
Oct 24, 2023
Healthy Adults Trial in Dallas (Sitravatinib 50 mg, Sitravatinib 100 mg, Itraconazole)
Recruiting
- Healthy Adults
- Sitravatinib 50 mg
- +3 more
-
Dallas, TexasLabcorp Drug Development Clinical Research Unit
Feb 23, 2022
Health Volunteers Trial in Miami (CTP-543, Fluconazole)
Recruiting
- Health Volunteers
-
Miami, FloridaClinical Pharmacology of Miami, LLC
Jul 26, 2022
Type 2 Diabetes Trial in Daejeon (CT-L01 12.5/1,000 mg)
Completed
- Healthy
- CT-L01 12.5/1,000 mg
-
Daejeon, Korea, Republic ofChungnam National University Hospital
Jan 10, 2023
Long QT Syndrome Trial in West Bend (LQT-1213, Placebo, Dofetilide 250 µg Cap)
Active, not recruiting
- Long QT Syndrome
- LQT-1213
- +2 more
-
West Bend, WisconsinSpaulding Clinical Research, LLC
Jun 15, 2023
NSCLC Trial in Pittsburgh (M1774, Cemiplimab)
Not yet recruiting
- Non-Small Cell Lung Cancer
-
Pittsburgh, PennsylvaniaUPMC Cancer Center
May 22, 2023
Healthy Trial in Fair Lawn (Diclofenac Sodium Gel)
Recruiting
- Healthy
- Diclofenac Sodium Gel
-
Fair Lawn, New JerseyTKL Research
Jul 27, 2023
Activated PI3Kdelta Syndrome (APDS); PASLI Disease Trial in Worldwide (CDZ173)
Active, not recruiting
- Activated PI3Kdelta Syndrome (APDS); PASLI Disease
-
Bethesda, Maryland
- +7 more
Jul 22, 2022
Healthy Volunteers Trial in Berlin (Zoliflodacin Patheon)
Recruiting
- Healthy Volunteers
- Zoliflodacin Patheon
-
Berlin, GermanyParexel Early Phase Clinical Unit
Nov 22, 2022
Metastatic Colorectal Cancer, mCRC Trial in Guangzhou (Tislelizumab & Fruquintinib)
Not yet recruiting
- Metastatic Colorectal Cancer
- mCRC
- Tislelizumab & Fruquintinib
-
Guangzhou, Guangdong, China
- +1 more
Jan 25, 2023